| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.796 | 12.728 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Total Income - EUR | 36.796 | 12.731 | 26 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Total Expenses - EUR | 18.375 | 11.496 | 262 | 149 | 136 | 0 | 0 | - | 0 | 0 |
| Gross Profit/Loss - EUR | 18.421 | 1.235 | -236 | -149 | -136 | 0 | 0 | - | 0 | 0 |
| Net Profit/Loss - EUR | 17.317 | 854 | -237 | -149 | -136 | 0 | 0 | - | 0 | 0 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
Check the financial reports for the company - Pharmacons Business Retail Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Current Assets | 63.761 | 60.143 | 58.889 | 57.675 | 56.407 | 55.338 | 0 | - | 54.114 | 53.811 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Receivables | 62.716 | 60.090 | 58.720 | 57.643 | 56.370 | 55.301 | 0 | - | 54.078 | 53.776 |
| Cash | 1.045 | 53 | 170 | 32 | 37 | 37 | 0 | - | 36 | 36 |
| Shareholders Funds | 59.342 | 59.590 | 58.346 | 57.126 | 55.884 | 54.824 | 0 | - | 53.612 | 53.312 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 0 | - | 40 | 40 |
| Debts | 4.419 | 552 | 544 | 549 | 523 | 514 | 0 | - | 502 | 499 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Pharmacons Business Retail Srl